Skip to main content
. 2021 Nov 8;13:8377–8385. doi: 10.2147/CMAR.S329581

Table 3.

Univariate and Multivariate Analyses for OS

Definitive CCRT Adjuvant CCRT
Univariate Multivariate Univariate
HR 95% CI P value HR 95% CI P value HR 95% CI P value
Age, ≥65 0.85 0.37–1.94 0.69 0.89 0.38–2.11 0.80 0.26 0.07–0.95 0.04
Sex, Male 1.56 0.54–4.52 0.41 2.10 0.68–6.41 0.19 1.45 0.19–11.0 0.71
PS, ≥1 2.56 1.04–6.40 0.04 1.23 0.47–3.20 0.66 0.68 0.19–2.39 0.54
Smoking, Current/former 0.67 0.28–1.60 0.37 1.03 0.29–3.62 0.96
Primarysite, Naso/oropharynx 0.58 0.26–01.28 0.18 0.82 0.18–3.01 0.79
Stage, IV 3.99 1.83–8.73 <0.01 2.64 1.15–6.07 0.02 3.77 0.85–16.6 0.07
Baseline albumin, <4 4.01 1.88–8.56 <0.01 3.91 1.78–8.59 <0.01 0.62 0.22–1.72 0.36
Cachexia 5.81 2.72–12.41 <0.01 4.31 1.93–9.61 <0.01 0.64 0.20–2.01 0.45

Abbreviations: PS, performance status; CCRT, concurrent chemoradiotherapy.